THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS

[1] Anderson WAD, 1942, ARCH PATHOL, V33, P677

[2] ASCHOFF LUDWIG, 1928, ACTA PATH ET MICROBIOL SCANDINAVICA, V5, P338

[3] Barkan G., 1937, KLIN WCHNSCHR, V37, P1265, DOI 10.1007/BF01784206

[4] BINGOLD K, 1932, HDB ALLGEMEINEN HAMA, V1, P601

[5] Brugsch T, 1924, BIOCHEM Z, V147, P253

[6] BRUGSCH T, 1912, Z EXP PATHOL THERAP, V11, P508

[7] BRUGSCH T, 1911, Z EXP PATHOL THERAP, V8, P639

[8] BRUGSCH T, 1911, Z EXP PATHOL THERAP, V8, P645

[9] DUESBERG R, 1934, ARCH EXP PATHOL PH, V174, P305

[10] DUESBERG R, 1938, KLIN WOCHENSCHR, V17, P1353

[1] Anderson WAD, 1942, ARCH PATHOL, V33, P677

[2] ASCHOFF LUDWIG, 1928, ACTA PATH ET MICROBIOL SCANDINAVICA, V5, P338

[3] Barkan G., 1937, KLIN WCHNSCHR, V37, P1265, DOI 10.1007/BF01784206

[4] BINGOLD K, 1932, HDB ALLGEMEINEN HAMA, V1, P601

[5] Brugsch T, 1924, BIOCHEM Z, V147, P253

[6] BRUGSCH T, 1912, Z EXP PATHOL THERAP, V11, P508

[7] BRUGSCH T, 1911, Z EXP PATHOL THERAP, V8, P639

[8] BRUGSCH T, 1911, Z EXP PATHOL THERAP, V8, P645

[9] DUESBERG R, 1934, ARCH EXP PATHOL PH, V174, P305

[10] DUESBERG R, 1938, KLIN WOCHENSCHR, V17, P1353